Lv3
248 积分 2024-06-30 加入
Hepatocellular carcinoma
8天前
已完结
Combination immunotherapy for hepatocellular carcinoma
8天前
已完结
Evolving therapeutic landscape of advanced hepatocellular carcinoma
8天前
已完结
Hepatocellular carcinoma
8天前
已完结
Immunotherapies for hepatocellular carcinoma
8天前
已完结
Combination locoregional and systemic therapies in hepatocellular carcinoma
8天前
已完结
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
10天前
已关闭
Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study
1个月前
已完结
Targeting KRAS in cancer
1个月前
已完结
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach
1个月前
已完结
皖公网安备34019202002308
